Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improved Factor VIII Inhibitor Evaluation

NCT02726139 is registered in ClinicalTrials.gov with Boston VA Research Institute, Inc. as lead sponsor.

NCT NCT02726139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02726139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improved Factor VIII Inhibitor Evaluation
Lead sponsor
Boston VA Research Institute, Inc.
Phase
Observational
Overall status
Withdrawn
Start date
July 15, 2016
Completion date
January 25, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia, hemophilia a